Utilizing the differential FKBP1A gene expression in circulating WBCs of pancreatic cancer patients is simple, less invasive, and exhibited high sensitivity in our study, when compared to the conventional serum biomarker CA19-9 and imaging methods (MRI). The gene discussed is FKBP1A; the disease is pancreatic neoplasm.